Sign in to view content

Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved Diabetic Macular Edema

Carl W. Baker, MD, FASRS

Video
Published 2019

Carl W. Baker, MD interviewed by Aleksandra Rachitskaya, MD

Related

Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018
Silicone Oil Droplets in the Vitreous After Intravitreal Injection With a Silicone Oil-Free and a Siliconized Insulin Syringe: A Randomized Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2024
Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022

Category: Diabetic Retinopathy

See more